Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Free Cash Flow (2016 - 2025)

iBio (IBIO) has disclosed Free Cash Flow for 16 consecutive years, with -$5.8 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 48.6% to -$5.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$19.2 million through Dec 2025, down 17.31% year-over-year, with the annual reading at -$15.3 million for FY2025, 18.58% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$5.8 million at iBio, down from -$5.7 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$3.1 million in Q1 2025, with the low at -$16.4 million in Q3 2022.
  • Average Free Cash Flow over 5 years is -$7.2 million, with a median of -$5.6 million recorded in 2023.
  • The sharpest move saw Free Cash Flow tumbled 116.39% in 2021, then surged 67.51% in 2023.
  • Over 5 years, Free Cash Flow stood at -$12.8 million in 2021, then increased by 17.4% to -$10.6 million in 2022, then surged by 55.56% to -$4.7 million in 2023, then rose by 17.76% to -$3.9 million in 2024, then crashed by 48.6% to -$5.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$5.8 million, -$5.7 million, and -$4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.